81 related articles for article (PubMed ID: 1399417)
1. Superoxide dismutase in the anterior chamber and the vitreous of diabetic patients.
Kernell A; Lundh BL; Marklund SL; Skoog KO; Björkstén B
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3131-5. PubMed ID: 1399417
[TBL] [Abstract][Full Text] [Related]
2. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal acid hydrolases in vitreous fluid of patients with proliferative diabetic retinopathy.
Nakazawa M; Tamai M
Jpn J Ophthalmol; 1991; 35(3):331-8. PubMed ID: 1770674
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase isoenzymes in the human eye.
Behndig A; Svensson B; Marklund SL; Karlsson K
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):471-5. PubMed ID: 9501855
[TBL] [Abstract][Full Text] [Related]
5. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients.
Lee SJ; Choi MG
Metabolism; 2006 Dec; 55(12):1681-8. PubMed ID: 17142144
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
7. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers in aqueous humor of patients with senile cataracts.
Sawada H; Fukuchi T; Abe H
Curr Eye Res; 2009 Jan; 34(1):36-41. PubMed ID: 19172468
[TBL] [Abstract][Full Text] [Related]
9. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract.
Holekamp NM; Shui YB; Beebe D
Am J Ophthalmol; 2006 Jun; 141(6):1027-32. PubMed ID: 16765670
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
11. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
Sivan E; Lee YC; Wu YK; Reece EA
Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant enzymes and diabetic retinopathy.
Yildirim Z; Uçgun NI; Kiliç N; Gürsel E; Sepici-Dinçel A
Ann N Y Acad Sci; 2007 Apr; 1100():199-206. PubMed ID: 17460179
[TBL] [Abstract][Full Text] [Related]
13. Levels of iron, zinc, and copper in aqueous humor, lens, and serum in nondiabetic and diabetic patients: their relation to cataract.
Aydin E; Cumurcu T; Ozugurlu F; Ozyurt H; Sahinoglu S; Mendil D; Hasdemir E
Biol Trace Elem Res; 2005; 108(1-3):33-41. PubMed ID: 16327057
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
15. Blood antioxidant parameters in patients with diabetic retinopathy.
Siemianowicz K; Gminski J; Telega A; Wójcik A; Posielezna B; Grabowska-Bochenek R; Francuz T
Int J Mol Med; 2004 Sep; 14(3):433-7. PubMed ID: 15289896
[TBL] [Abstract][Full Text] [Related]
16. [Peroxidative reactions in the vitreous as related to diabetic retinopathy].
Tanaka Y
Nippon Ganka Gakkai Zasshi; 1998 Sep; 102(9):576-82. PubMed ID: 9785854
[TBL] [Abstract][Full Text] [Related]
17. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.
Kim T; Kim SJ; Kim K; Kang UB; Lee C; Park KS; Yu HG; Kim Y
Proteomics; 2007 Nov; 7(22):4203-15. PubMed ID: 17955474
[TBL] [Abstract][Full Text] [Related]
18. Anterior segment complications in diabetic patients following extracapsular cataract extraction and posterior chamber intraocular lens implantation.
Krupsky S; Zalish M; Oliver M; Pollack A
Ophthalmic Surg; 1991 Sep; 22(9):526-30. PubMed ID: 1945278
[TBL] [Abstract][Full Text] [Related]
19. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
20. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
